Development of enzymes in medical technology has been as extensive an application as that of its applications in other industrial sectors. There are a variety of enzymes that can be used in different therapeutics. At present, extracellular application of enzymes, which involves removal of toxic substances and treatment of disorders in blood circulation, has been found to be the most successful one in medical technology. Enzymes are biological catalysts that can be used as therapeutic agents for the treatment of metabolic diseases.
Download exclusive Sample of this report:
Enzymes are produced by living cells and act as catalysts for increasing the cell reaction rate in an organism. Without enzymes, the cell reaction rate would be much slower for life sustenance. All enzymes are specific proteins and thus have a tertiary structure. Each enzyme has a specific shape and a specific action site. Enzymes are extensively used in medical applications. Such applications mainly include pharmaceutical products. The vital importance of use of enzymes in disease diagnosis and drug development, and their efficacy in this field is the primary driver influencing the demand for medical enzymes technology. These enzymes are categorized as therapeutic enzymes, diagnostic enzymes, and enzymes for biomedical research. The therapeutic enzymes segment is the largest one in the category of medical enzymes. On the other hand, use of enzymes in molecular research will undergo rapid progress in the next five years.
North America is the largest market for medical enzyme technology since large scale biomolecular research in this field and drug development is carried out here. The Asia-Pacific market will undergo the fastest growth in enzymes technology owing to the growth and development in healthcare infrastructure and the supportive framework established by governments.
Some of the major market players in this field are Agilent Technologies, Asahi Kasei Pharma, Digestive Care Inc., Life Technologies Corporation, and Thermo Fisher Scientific Inc.